Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX)
CUSIP: 47010C888
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 6,991,905
- Total 13F shares
- 95,488
- Share change
- +81,616
- Total reported value
- $222,851
- Price per share
- $2.33
- Number of holders
- 9
- Value change
- +$193,853
- Number of buys
- 4
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 47010C888?
CUSIP 47010C888 identifies JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 47010C888:
Top shareholders of JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC |
3/4/5
|
10%+ Owner |
8.6%
|
600,000
|
$1,284,000 | — | 28 Aug 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
65,002
|
$779,374 | $0 | 20 May 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
4.6%
|
164,204
|
$346,470 | +$36,300 | 30 Sep 2025 | |
| Uptown Capital, LLC |
13D/G
|
John Fife and Fredrick Waid |
9.9%
|
1,290,000
|
$322,500 | $0 | 29 Jan 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
11,173
|
$28,156 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
1,591
|
$4,009 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
702
|
$2,000 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
200
|
$504 | — | 30 Jun 2025 | |
| Leonteq Securities AG |
13F
|
Company |
0%
|
188
|
$474 | — | 30 Jun 2025 | |
| Gregory J. Divis |
3/4/5
|
Director |
—
class O/S missing
|
12,133
|
$364 | — | 18 May 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
10
|
$25 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4
|
$10 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
4
|
$10 | — | 30 Jun 2025 |
Institutional Holders of Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.